Context-Dependent Regulation of Type17 Immunity by Microbiota at the Intestinal Barrier

T-helper-17 (Th17) cells and related IL-17-producing (type17) lymphocytes are abundant at the epithelial barrier. In response to bacterial and fungal infection, the signature cytokines IL-17A/F and IL-22 mediate the antimicrobial immune response and contribute to wound healing of injured tissues. Despite their protective function, type17 lymphocytes are also responsible for various chronic inflammatory disorders, including inflammatory bowel disease (IBD) and colitis associated cancer (CAC). A deeper understanding of type17 regulatory mechanisms could ultimately lead to the discovery of therapeutic strategies for the treatment of chronic inflammatory disorders and the prevention of cancer. In this review, we discuss the current understanding of the development and function of type17 immune cells at the intestinal barrier, focusing on the impact of microbiota-immune interactions on intestinal barrier homeostasis and disease etiology.

[1]  F. Repoila,et al.  Adaptation of the gut pathobiont Enterococcus faecalis to deoxycholate and taurocholate bile acids , 2022, Scientific Reports.

[2]  J. Silber,et al.  RANDOMIZED, DOUBLE-BLIND, PLACEBO (PBO)-CONTROLLED, SINGLE- AND MULTIPLE-DOSE PHASE 1 STUDY OF VE202, A DEFINED BACTERIAL CONSORTIUM FOR TREATMENT OF IBD: SAFETY AND COLONIZATION DYNAMICS OF A NOVEL LIVE BIOTHERAPEUTIC PRODUCT (LBP) IN HEALTHY ADULTS , 2022, Gastroenterology.

[3]  S. Beyaz,et al.  IL-17RA-signaling in Lgr5+ intestinal stem cells induces expression of transcription factor ATOH1 to promote secretory cell lineage commitment. , 2022, Immunity.

[4]  Jiannan Li,et al.  Treatment of Inflammatory Bowel Disease: A Comprehensive Review , 2021, Frontiers in Medicine.

[5]  A. Regev,et al.  Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity , 2021, Cell.

[6]  S. Teichmann,et al.  Redefining intestinal immunity with single-cell transcriptomics , 2021, Mucosal Immunology.

[7]  Mark S. Anderson,et al.  Antigen presentation by type 3 innate lymphoid cells instructs the differentiation of gut microbiota-specific regulatory T cells , 2021 .

[8]  Ryan M. O’Connell,et al.  Epithelial-myeloid exchange of MHC class II constrains immunity and microbiota composition , 2021, Cell reports.

[9]  Huiyu Wang,et al.  Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis. , 2021, Cancer letters.

[10]  L. Hooper,et al.  Serum amyloid A delivers retinol to intestinal myeloid cells to promote adaptive immunity , 2021, Science.

[11]  J. D. Di Santo,et al.  Group 3 innate lymphoid cells mediate host defense against attaching and effacing pathogens. , 2021, Current opinion in microbiology.

[12]  H. Sokol,et al.  Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal γδ T cells. , 2021, Cell reports.

[13]  Vasileios Bekiaris,et al.  Evolved to protect, designed to destroy: IL‐17‐producing γδ T cells in infection, inflammation, and cancer , 2021, European journal of immunology.

[14]  A. Engelbrecht,et al.  Serum Amyloid A Promotes Inflammation-Associated Damage and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2021, Cellular and molecular gastroenterology and hepatology.

[15]  Y. Belkaid,et al.  Control of Immunity by the Microbiota. , 2021, Annual review of immunology.

[16]  Chang H. Kim.  Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids , 2021, Cellular & Molecular Immunology.

[17]  Maxim N. Artyomov,et al.  Single-cell analyses of Crohn’s disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions , 2021, Nature Communications.

[18]  A. Lehuen,et al.  MAIT cells, guardians of skin and mucosa? , 2021, Mucosal Immunology.

[19]  Cheng-Jian Xu,et al.  Identification of Novel Population-Specific Cell Subsets in Chinese Ulcerative Colitis Patients Using Single-Cell RNA Sequencing , 2021, Cellular and molecular gastroenterology and hepatology.

[20]  Qiuran Xu,et al.  Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies , 2021, Journal of immunology research.

[21]  C. Huttenhower,et al.  A Bacterial Bile Acid Metabolite Modulates Treg Activity through the Nuclear Hormone Receptor NR4A1 , 2021, bioRxiv.

[22]  P. Klenerman,et al.  MAIT Cells in Barrier Tissues: Lessons from Immediate Neighbors , 2020, Frontiers in Immunology.

[23]  M. Geuking,et al.  Microbial modulation of intestinal T helper cell responses and implications for disease and therapy , 2020, Mucosal Immunology.

[24]  C. Huttenhower,et al.  A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis , 2020, Gastroenterology.

[25]  R. Weersma,et al.  Understanding human gut diseases at single-cell resolution , 2020, Human molecular genetics.

[26]  D. Besselsen,et al.  Intestinal Epithelial Expression of MHCII Determines Severity of Chemical, T Cell-Induced, and Infectious Colitis in Mice. , 2020, Gastroenterology.

[27]  Liang Zhou,et al.  Ahr-Foxp3-RORγt axis controls gut homing of CD4+ T cells by regulating GPR15 , 2020, Science Immunology.

[28]  T. Hinks,et al.  MAIT Cell Activation and Functions , 2020, Frontiers in Immunology.

[29]  E. Elinav,et al.  Interaction between microbiota and immunity in health and disease , 2020, Cell Research.

[30]  K. Takeda,et al.  Interaction Between the Microbiota, Epithelia, and Immune Cells in the Intestine. , 2020, Annual review of immunology.

[31]  M. Eberl.  Antigen recognition by human γδ T cells: one step closer to knowing , 2020, Immunology and cell biology.

[32]  V. Sexl,et al.  Microbiota-induced tissue signals regulate ILC3-mediated antigen presentation , 2020, Nature Communications.

[33]  Aldert L. Zomer,et al.  Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease , 2020, Nature Communications.

[34]  A. Diefenbach,et al.  Innate Lymphoid Cell-Epithelial Cell Modules Sustain Intestinal Homeostasis. , 2020, Immunity.

[35]  M. Fischbach,et al.  Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation. , 2020, Cell host & microbe.

[36]  F. Jamali,et al.  Single dose pharmacokinetics and bioavailability of glucosamine in the rat. , 2002, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[37]  G. Núñez,et al.  Host–microbiota interactions in inflammatory bowel disease , 2020, Nature Reviews Immunology.

[38]  S. Way,et al.  IL-17 producing γδ T cells protect against Clostridium difficile infection. , 2020, The Journal of clinical investigation.

[39]  P. Hahn,et al.  Feeding-dependent VIP neuron-ILC3 circuit regulates the intestinal barrier , 2020, Nature.

[40]  E. Quigley,et al.  The microbiome and inflammatory bowel disease. , 2020, The Journal of allergy and clinical immunology.

[41]  E. Kenigsberg,et al.  Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease , 2019, Cell.

[42]  C. Benoist,et al.  Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis , 2019, Nature.

[43]  N. Waddell,et al.  MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota. , 2019, Immunity.

[44]  Yu Liu,et al.  Protective Role of Fecal Microbiota Transplantation on Colitis and Colitis-Associated Colon Cancer in Mice Is Associated With Treg Cells , 2019, Front. Microbiol..

[45]  W. Garrett,et al.  Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity. , 2019, Immunity.

[46]  Jonathan L. Linehan,et al.  MAIT cells are imprinted by the microbiota in early life and promote tissue repair , 2019, Science.

[47]  E. Hsiao,et al.  Microbiomes as sources of emergent host phenotypes , 2019, Science.

[48]  Lajia Zha,et al.  Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome , 2019, Pathogens.

[49]  M. Hepworth,et al.  Functional interactions between innate lymphoid cells and adaptive immunity , 2019, Nature Reviews Immunology.

[50]  G. Cicero,et al.  Characterization of γδ T cells in intestinal mucosa from patients with early onset or long standing inflammatory bowel disease and their correlation with clinical status. , 2019, Journal of Crohn's & colitis.

[51]  Aviv Regev,et al.  Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis , 2019, Cell.

[52]  Y. Li,et al.  The Intestine Harbors Functionally Distinct Homeostatic Tissue-Resident and Inflammatory Th17 Cells , 2019, Immunity.

[53]  K. Honda,et al.  Endocytosis of commensal antigens by intestinal epithelial cells regulates mucosal T cell homeostasis , 2019, Science.

[54]  Pawan Kumar,et al.  Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis , 2019, Front. Immunol..

[55]  Zheng Kuang,et al.  Epithelial retinoic acid receptor β regulates serum amyloid A expression and vitamin A-dependent intestinal immunity , 2019, Proceedings of the National Academy of Sciences.

[56]  K. Bittinger,et al.  Antigen-presenting ILC3 regulate T cell–dependent IgA responses to colonic mucosal bacteria , 2019, The Journal of experimental medicine.

[57]  J. Gisbert,et al.  Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity , 2019, Immunity.

[58]  W. Shi,et al.  c-Maf-dependent Treg cell control of intestinal TH17 cells and IgA establishes host–microbiota homeostasis , 2019, Nature Immunology.

[59]  Boris Lamp,et al.  The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes , 2019, Nature Communications.

[60]  D. Gevers,et al.  Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and ROR&ggr;t+ Regulatory T Cells and Exacerbate Colitis in Mice , 2019, Immunity.

[61]  M. Hattori,et al.  Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis , 2019, Nature Microbiology.

[62]  Judy H. Cho,et al.  Single-Cell Analysis of Crohn’s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy , 2019, Cell.

[63]  T. McGaha,et al.  The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment. , 2018, Trends in immunology.

[64]  P. Klenerman,et al.  TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions , 2018, bioRxiv.

[65]  M. Fischbach,et al.  Bile acid metabolites control Th17 and Treg cell differentiation , 2018, bioRxiv.

[66]  Ramnik J. Xavier,et al.  T Helper Cell Cytokines Modulate Intestinal Stem Cell Renewal and Differentiation , 2018, Cell.

[67]  Xiaotian Chen,et al.  Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1. , 2018, Inflammatory bowel diseases.

[68]  E. Adams,et al.  MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage , 2018, Science Immunology.

[69]  T. Wakai,et al.  Genomic characterization of colitis-associated colorectal cancer , 2018, World Journal of Surgical Oncology.

[70]  Harry Sokol,et al.  Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. , 2018, Cell host & microbe.

[71]  B. Helmink,et al.  The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. , 2018, Cancer cell.

[72]  Zhenyu Yang,et al.  Roseburia intestinalis inhibits interleukin-17 excretion and promotes regulatory T cells differentiation in colitis , 2018, Molecular medicine reports.

[73]  G. Liguori,et al.  Mucosa-associated microbiota dysbiosis in colitis associated cancer , 2018, Gut microbes.

[74]  D. Pardoll,et al.  Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. , 2018, Cell host & microbe.

[75]  Richard Bonneau,et al.  c-Maf-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont , 2018, Nature.

[76]  M. Kronenberg,et al.  Improved Detection of Cytokines Produced by Invariant NKT Cells , 2017, Scientific Reports.

[77]  Liang Zhou,et al.  The Aryl Hydrocarbon Receptor Preferentially Marks and Promotes Gut Regulatory T Cells. , 2017, Cell reports.

[78]  L. Brockmann,et al.  TH17 Cell and Epithelial Cell Crosstalk during Inflammatory Bowel Disease and Carcinogenesis , 2017, Front. Immunol..

[79]  A. Travis,et al.  Human Gut Symbiont Roseburia hominis Promotes and Regulates Innate Immunity , 2017, Front. Immunol..

[80]  L. Sechi,et al.  Detection of enterotoxigenic Bacteroides fragilis in patients with ulcerative colitis , 2017, Gut Pathogens.

[81]  P. Tso,et al.  Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease , 2017, Front. Immunol..

[82]  Alberto Martin,et al.  Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development. , 2017, Seminars in immunology.

[83]  G. Victora,et al.  Intestinal Epithelial and Intraepithelial T Cell Crosstalk Mediates a Dynamic Response to Infection , 2017, Cell.

[84]  B. Stockinger,et al.  The dichotomous nature of T helper 17 cells , 2017, Nature Reviews Immunology.

[85]  L. Brockmann,et al.  Regulation of TH17 Cells and Associated Cytokines in Wound Healing, Tissue Regeneration, and Carcinogenesis , 2017, International journal of molecular sciences.

[86]  Y. Belkaid,et al.  Homeostatic Immunity and the Microbiota. , 2017, Immunity.

[87]  Y. Li,et al.  Feedback Control of AHR Signaling Regulates Intestinal Immunity , 2017, Nature.

[88]  M. Hepworth,et al.  Functional and phenotypic heterogeneity of group 3 innate lymphoid cells , 2017, Immunology.

[89]  S. Targan,et al.  Therapeutic Targets in Inflammatory Bowel Disease: Current and Future , 2016 .

[90]  C. Benoist,et al.  Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice , 2016, Proceedings of the National Academy of Sciences.

[91]  C. Streutker,et al.  NKT Cell–Deficient Mice Harbor an Altered Microbiota That Fuels Intestinal Inflammation during Chemically Induced Colitis , 2016, The Journal of Immunology.

[92]  S. Lynch,et al.  Disease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis Patients , 2016, mBio.

[93]  K. Honda,et al.  The microbiota in adaptive immune homeostasis and disease , 2016, Nature.

[94]  Ajay S. Gulati,et al.  Intestinal Interleukin-17 Receptor Signaling Mediates Reciprocal Control of the Gut Microbiota and Autoimmune Inflammation. , 2016, Immunity.

[95]  Rona S. Gertner,et al.  Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity , 2015, Cell.

[96]  J. McCluskey,et al.  Recognition of Vitamin B Precursors and Byproducts by Mucosal Associated Invariant T Cells* , 2015, The Journal of Biological Chemistry.

[97]  M. Hattori,et al.  Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells , 2015, Cell.

[98]  Ana I. Domingos,et al.  An IL-23R/IL-22 Circuit Regulates Epithelial Serum Amyloid A to Promote Local Effector Th17 Responses , 2015, Cell.

[99]  Liza Konnikova,et al.  Individual intestinal symbionts induce a distinct population of RORγ+ regulatory T cells , 2015, Science.

[100]  D. Voehringer,et al.  The microbiota regulates type 2 immunity through RORγt+ T cells , 2015, Science.

[101]  T. Hohl,et al.  Intestinal Monocyte-Derived Macrophages Control Commensal-Specific Th17 Responses. , 2015, Cell reports.

[102]  J. Casanova,et al.  Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations , 2015, Science.

[103]  K. Chowdhury,et al.  The aryl hydrocarbon receptor/microRNA-212/132 axis in T cells regulates IL-10 production to maintain intestinal homeostasis. , 2015, International immunology.

[104]  B. Bernstein,et al.  Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation , 2015, Nature.

[105]  M. Karin,et al.  The IL-23 to IL-17 cascade inflammation-related cancers. , 2015, Clinical and experimental rheumatology.

[106]  M. Sun,et al.  Regulatory immune cells in regulation of intestinal inflammatory response to microbiota , 2015, Mucosal Immunology.

[107]  V. Cerundolo,et al.  MR1-Restricted Mucosal-Associated Invariant T Cells and Their Activation during Infectious Diseases , 2015, Front. Immunol..

[108]  H. Sokol,et al.  Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease , 2015, Gut.

[109]  Michael A. Fischbach,et al.  A biosynthetic pathway for a prominent class of microbiota-derived bile acids , 2015, Nature chemical biology.

[110]  M. Farrar,et al.  Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria–specific CD4+ T cells , 2015, Science.

[111]  Vrajesh V. Parekh,et al.  The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their Products , 2015, Front. Immunol..

[112]  R. Knight,et al.  Microbiota and Host Nutrition across Plant and Animal Kingdoms. , 2015, Cell host & microbe.

[113]  S. Hanauer,et al.  Briakinumab for Treatment of Crohn's Disease: Results of a Randomized Trial , 2015, Inflammatory bowel diseases.

[114]  P. Goldberg,et al.  Quantitative Profiling of Colorectal Cancer-Associated Bacteria Reveals Associations between Fusobacterium spp., Enterotoxigenic Bacteroides fragilis (ETBF) and Clinicopathological Features of Colorectal Cancer , 2015, PloS one.

[115]  R. Guo,et al.  Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axis , 2015, Mucosal Immunology.

[116]  M. Karin,et al.  Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. , 2014, Immunity.

[117]  B. Becher,et al.  Innate lymphoid cells regulate intestinal epithelial cell glycosylation , 2014, Science.

[118]  Florent Ginhoux,et al.  Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny , 2014, Nature Reviews Immunology.

[119]  Patrick D Schloss,et al.  Structure of the gut microbiome following colonization with human feces determines colonic tumor burden , 2014, Microbiome.

[120]  T. Denning,et al.  Specific Microbiota-Induced Intestinal Th17 Differentiation Requires MHC Class II but Not GALT and Mesenteric Lymph Nodes , 2014, The Journal of Immunology.

[121]  I. Ivanov,et al.  Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. , 2014, Immunity.

[122]  Jonathan L. Linehan,et al.  Focused Specificity of Intestinal Th17 Cells towards Commensal Bacterial Antigens , 2014, Nature.

[123]  Y. Belkaid,et al.  Role of the Microbiota in Immunity and Inflammation , 2014, Cell.

[124]  J. Goedert,et al.  Human gut microbiome and risk for colorectal cancer. , 2013, Journal of the National Cancer Institute.

[125]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[126]  M. Hattori,et al.  Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota , 2013, Nature.

[127]  F. Bushman,et al.  Innate lymphoid cells regulate CD4+ T cell responses to intestinal commensal bacteria , 2013, Nature.

[128]  V. Soumelis,et al.  Human inflammatory dendritic cells induce Th17 cell differentiation. , 2013, Immunity.

[129]  A. Waisman,et al.  A T-bet gradient controls the fate and function of CCR6−RORγt+ innate lymphoid cells , 2013, Nature.

[130]  D. Littman,et al.  Microbiota Restrict Trafficking of Bacteria to Mesenteric Lymph Nodes by CX3CR1hi Cells , 2013, Nature.

[131]  K. Takeda,et al.  Regulation of intestinal homeostasis by innate and adaptive immunity. , 2012, International immunology.

[132]  J. Kolls,et al.  Targeting IL-17 and TH17 cells in chronic inflammation , 2012, Nature Reviews Drug Discovery.

[133]  Casey T. Weaver,et al.  Reciprocal interactions of the intestinal microbiota and immune system , 2012, Nature.

[134]  S. Targan,et al.  Mo2083 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease , 2012 .

[135]  A. Regev,et al.  Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.

[136]  R. Siebert,et al.  Microbial Exposure During Early Life Has Persistent Effects on Natural Killer T Cell Function , 2012, Science.

[137]  E. Feuille.  The Antibacterial Lectin RegIII-Gamma Promotes the Spatial Segregation of Microbiota and Host in the Intestine , 2012 .

[138]  S. Rutz,et al.  Transcription factor c-Maf mediates the TGF-β-dependent suppression of IL-22 production in TH17 cells , 2011, Nature Immunology.

[139]  R. Ley,et al.  The Antibacterial Lectin RegIIIγ Promotes the Spatial Segregation of Microbiota and Host in the Intestine , 2011, Science.

[140]  C. Hsieh,et al.  Peripheral education of the immune system by colonic commensal microbiota , 2011, Nature.

[141]  Jim Hu,et al.  Complexity of dendritic cell subsets and their function in the host immune system , 2011, Immunology.

[142]  S. Mazmanian,et al.  Pathobionts of the gastrointestinal microbiota and inflammatory disease. , 2011, Current opinion in immunology.

[143]  A. DeFranco,et al.  γδ intraepithelial lymphocytes are essential mediators of host–microbial homeostasis at the intestinal mucosal surface , 2011, Proceedings of the National Academy of Sciences.

[144]  C. Bodemer,et al.  Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity , 2011, Science.

[145]  D. Littman,et al.  Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. , 2011, Gastroenterology.

[146]  K. Honda,et al.  Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.

[147]  P. Vandamme,et al.  Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives , 2011, Gut.

[148]  Michael A McGuckin,et al.  Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria , 2010, The American Journal of Gastroenterology.

[149]  F. Powrie,et al.  Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells , 2010, Immunity.

[150]  D. Kasper,et al.  Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells. , 2010, Cell host & microbe.

[151]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[152]  L. Hooper,et al.  Immune responses to the microbiota at the intestinal mucosal surface. , 2009, Immunity.

[153]  M. Veldhoen,et al.  Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells , 2009, The Journal of experimental medicine.

[154]  Andreas Diefenbach,et al.  RORγt and commensal microflora are required for the differentiation of mucosal interleukin 22–producing NKp46+ cells , 2009, Nature Immunology.

[155]  Shinichiro Sawa,et al.  Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. , 2008, Immunity.

[156]  R Balfour Sartor,et al.  Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. , 2008, Cell host & microbe.

[157]  P. Rutgeerts,et al.  A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. , 2008, Gastroenterology.

[158]  S. Mazmanian,et al.  A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.

[159]  H. Weiner,et al.  Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor , 2008, Nature.

[160]  Y. Belkaid,et al.  A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism , 2007, The Journal of experimental medicine.

[161]  A. Sher,et al.  IL-23 plays a key role in Helicobacter hepaticus–induced T cell–dependent colitis , 2006, The Journal of experimental medicine.

[162]  F. Powrie,et al.  Interleukin-23 drives innate and T cell–mediated intestinal inflammation , 2006, The Journal of experimental medicine.

[163]  J. Shellito,et al.  Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae , 2005, The Journal of experimental medicine.

[164]  S. Mazmanian,et al.  An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System , 2005, Cell.

[165]  T. Hibi,et al.  A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. , 2004, Gastroenterology.

[166]  T. Warner,et al.  Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. , 2002, The American journal of pathology.

[167]  F. Powrie,et al.  Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus , 1997, Infection and immunity.

[168]  P. Bland,et al.  MHC class II expression by the gut epithelium. , 1988, Immunology today.